What is Dermazone Solutions?
Based in St. Petersburg, Florida, Dermazone Solutions operates at the intersection of advanced material science and pharmaceutical manufacturing. The company distinguishes itself through its patented nanosphere delivery systems, which serve as the technological backbone for its diverse product lines, including Celazome, Kara Vita, and Hyssop Health. Beyond its own brands, the company leverages its FDA-registered, state-of-the-art manufacturing facility to provide comprehensive contract manufacturing, private labeling, and fulfillment services. By integrating complex formulation capabilities with high-capacity packaging and distribution, Dermazone functions as a critical infrastructure partner for both pharmaceutical and cosmeceutical enterprises seeking precision delivery solutions.
How much funding has Dermazone Solutions raised?
Dermazone Solutions has raised a total of $424K across 1 funding round:
Debt
$424K
Debt (2021): $424K with participation from PPP
Key Investors in Dermazone Solutions
PPP
Public-Private Partnership
What's next for Dermazone Solutions?
The recent influx of capital is expected to accelerate the company's operational scaling and R&D initiatives. Given the late-stage nature of this financing, Dermazone is well-positioned to expand its manufacturing throughput and potentially broaden its patent portfolio within the nanotech sector. Strategic priorities likely include optimizing supply chain efficiencies and deepening its penetration into the global cosmeceutical market. As the firm transitions into this next phase of growth, the focus will remain on leveraging its proprietary delivery systems to capture additional market share in high-growth therapeutic and aesthetic categories, ensuring long-term value creation for stakeholders.
See full Dermazone Solutions company page
